TSX:WEEDPharmaceuticals
Evaluating Canopy Growth (TSX:WEED) After Schedule III Reform Hopes Lift Cannabis Stocks
Reports that President Trump intends to move marijuana to Schedule III have jolted Canopy Growth (TSX:WEED) back into focus, with investors quickly repricing its prospects for U.S. banking access and expansion.
See our latest analysis for Canopy Growth.
That policy buzz comes on top of Canopy’s December rollout of high potency Claybourne Gassers vapes in Canada. Together these catalysts have powered a sharp 30 day share price return of 52.32%, even though the 1 year total shareholder return...